New Zealand vs Norway: Cause of death, by non-communicable diseases, ages 15-59, male
New Zealand
71.6%
in 2021
Norway
71.1%
in 2021
New Zealand rank
27th
Norway rank
30th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- New Zealand
- Norway
How they compare
New Zealand currently reports 71.6% against 71.1% in Norway, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Norway ahead.
New Zealand ranks 27th and Norway ranks 30th of 185 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | New Zealand | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.4% | 75.4% | 8.1% | Norway |
| 2010s | 69.8% | 75.6% | 5.8% | Norway |
| 2020s | 71.4% | 72.5% | 1.1% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, New Zealand or Norway?
- New Zealand, at 71.6% against 71.1% in Norway as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between New Zealand and Norway?
- 0.5%, with New Zealand ahead.
- How many years of comparable data are there for New Zealand and Norway?
- 6 years are reported by both, from 2000 to 2021.
- How do New Zealand and Norway rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- New Zealand ranks 27th and Norway ranks 30th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.